Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
24.69
+1.91 (8.38%)
Apr 13, 2026, 12:15 PM EDT - Market open
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $788.73 million as of April 13, 2026. Its market cap has increased by 1,065.38% in one year.
Market Cap
788.73M
Enterprise Value
575.19M
1-Year Change
1,065.38%
Ranking
Category
Stock Price
$24.69
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $788.73M, an increase of 49.19%. That is a compound annual growth rate of 20.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 727.72M | 31.60% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 789.10M |
| Kura Oncology | 765.82M |
| Relmada Therapeutics | 764.64M |
| Design Therapeutics | 749.93M |
| MeiraGTx Holdings | 730.57M |
| Lexicon Pharmaceuticals | 728.73M |
| Tenax Therapeutics | 725.58M |
| SpyGlass Pharma | 693.60M |